- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03589404
Effect of Pneumoperitoneum Anterior Abdominal Wall Tissue Oxygenation
December 17, 2019 updated by: Korgün Ökmen, Bursa Yüksek İhtisas Education and Research Hospital
Investigation of the Effect of Pneumoperitoneum Anterior Abdominal Wall Tissue Oxygenation on Laparoscopic Cholecystectomy
During laparoscopic surgery, the abdomen is inflated with carbon dioxide for abdominal imaging and increased intraabdominal pressure affects intraabdominal structures and abdominal wall.
Study Overview
Detailed Description
The investigators aimed to investigate the effects of pneumoperitoneum administered during laparoscopic cholecystectomy on abdominal wall oxygenation and postoperative pain scores.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bursa, Turkey, 16110
- Bursa Yuksek Ihtisas Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who were in the American Society of Anesthesiologists (ASA) I-III class
- Underwent laparoscopic cholecystectomy
Exclusion Criteria:
- Previous surgeon surgeon
- Local anesthetic allergy,
- Bleeding is a diathesis disorder
- Mental impairment,
- Allergic to the drugs used,
- Patients who are not reluctant to participate in the study,
- Presence of infection in the block area,
- Patients whose body mass index is over 30
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: rso2
The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.
|
The regional oxymetry probe will be placed in the abdominal region of the umbilicus in the middle clavicular line before the disease operation begins.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
rso2
Time Frame: perioperative
|
The regional oxymetry probe (Medtronic Quick Assist INVOS™ (In-Vivo Optical Spectroscopy) Cerebral/Somatic Oximeter) will be placed in the abdominal region of the umbilicus in the middle clavicular line
|
perioperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale
Time Frame: Postoperative 24 hours
|
Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS).
(0=no pain, 10=intolerable pain)
|
Postoperative 24 hours
|
analgesic use
Time Frame: Postoperative 24 hours
|
analgesic use
|
Postoperative 24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Korgün Ökmen, M.D, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 15, 2018
Primary Completion (Actual)
November 15, 2019
Study Completion (Actual)
November 15, 2019
Study Registration Dates
First Submitted
July 5, 2018
First Submitted That Met QC Criteria
July 16, 2018
First Posted (Actual)
July 17, 2018
Study Record Updates
Last Update Posted (Actual)
December 18, 2019
Last Update Submitted That Met QC Criteria
December 17, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-KAEK-25 2018/04-24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopy
-
TakedaCompleted
-
Kangbuk Samsung HospitalUnknown
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
-
M.D. Anderson Cancer CenterTerminatedLaparoscopyUnited States
-
University Hospital, Strasbourg, FranceRecruiting
-
Capital Medical UniversityCompleted
-
Czech Technical University in PragueMilitary University Hospital, PragueCompleted
-
Marko KraljevicUniversity Hospital, Basel, SwitzerlandRecruiting
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
Clinical Trials on rso2
-
Nevsehir Public HospitalCompleted
-
Meshalkin Research Institute of Pathology of CirculationCompletedPostoperative ComplicationsRussian Federation
-
University Health Network, TorontoCompleted
-
Montreal Heart InstituteUniversité de MontréalCompleted
-
Beijing Tiantan HospitalRecruitingPostoperative Delirium | AnesthesiaChina